Evidence map›Paper›PMID 33126886›Full record

ArticleMalaria journal2020

Health systems readiness and quality of inpatient malaria case-management in Kano State, Nigeria.

Abiodun A Ojo, Kolawole Maxwell, Olusola Oresanya, Justice Adaji, Prudence Hamade, James K Tibenderana, Saddiq S Abubakar, Bala M Audu, Ahmad Njidda, Aishatu B Gubio and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Abiodun A OjoMalaria Consortium, Abuja, Nigeria.
Kolawole MaxwellMalaria Consortium, Abuja, Nigeria.
Olusola OresanyaMalaria Consortium, Abuja, Nigeria.
Justice AdajiMalaria Consortium, Abuja, Nigeria.
Prudence HamadeMalaria Consortium, London, UK.
James K TibenderanaMalaria Consortium, London, UK.
Saddiq S AbubakarState Malaria Elimination Programme, Kano, Nigeria.
Bala M AuduNational Malaria Elimination Programme, Abuja, Nigeria.
Ahmad NjiddaNational Malaria Elimination Programme, Abuja, Nigeria.
Aishatu B GubioNational Malaria Elimination Programme, Abuja, Nigeria.
Robert W SnowKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Dejan ZurovacKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya. dzurovac@kemri-wellcome.org.ORCID http://orcid.org/0000-0001-8267-9026
AIDS Prevention Initiative in Nigeria · NGMalaria Consortium · GBAngkor Hospital for Children · KHKenya Medical Research Institute · KE

Funding

Department for International Development, UK Malaria Consortium's SUNMAP2 project
6 · The paper itself

Abstract

backgroundNigeria was among the first African countries to adopt and implement change of treatment policy for severe malaria from quinine to artesunate. Seven years after the policy change health systems readiness and quality of inpatient malaria case-management practices were evaluated in Kano State of Nigeria.

methodsA cross-sectional survey was undertaken in May 2019 at all public hospitals. Data collection comprised hospital assessments, interviews with inpatient health workers and data extraction from medical files for all suspected malaria patients admitted to the paediatric and medical wards in April 2019. Descriptive analyses included 22 hospitals, 154 health workers and 1,807 suspected malaria admissions analysed from malaria test and treat case-management perspective.

results73% of hospitals provided malaria microscopy, 27% had rapid diagnostic tests and 23% were unable to perform any parasitological malaria diagnosis. Artemisinin-based combination therapy (ACT) was available at 96% of hospitals, artemether vials at 68% while injectable quinine and artesunate were equally stocked at 59% of hospitals. 32%, 21% and 15% of health workers had been exposed to relevant trainings, guidelines and supervision respectively. 47% of suspected malaria patients were tested while repeat testing was rare (7%). 60% of confirmed severe malaria patients were prescribed artesunate. Only 4% of admitted non-severe test positive cases were treated with ACT, while 76% of test negative patients were prescribed an anti-malarial. Artemether was the most common anti-malarial treatment for non-severe test positive (55%), test negative (43%) and patients not tested for malaria (45%). In all categories of the patients, except for confirmed severe cases, artemether was more commonly prescribed for adults compared to children. 44% of artesunate-treated patients were prescribed ACT follow-on treatment. Overall compliance with test and treat policy for malaria was 13%.

conclusionsTranslation of new treatment policy for severe malaria into inpatient practice is compromised by lack of malaria diagnostics, stock-outs of artesunate and suboptimal health workers' practices. Establishment of the effective supply chain and on-going supportive interventions for health workers accompanied with regular monitoring of the systems readiness and clinical practices are urgently needed.

Indexed as

Case ManagementAntimalarialsChildChild, PreschoolCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHealth PersonnelHumansInpatientsMalaria, FalciparumMaleNigeriaPrevalenceAntimalarialsArtesunateCase-managementHospitalMalariaNigeriaSystems readinessTest and treat

Identifiers

PMID33126886
PMCPMC7602350
OpenAlexW3095272587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.